3Lockhat FB,Emembolu JE,Konje JC. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestre[J].Fertility and Sterility,2005,(08):398-404.
4Megavigan C J,Dockery P,Metaxa-Mariation V. Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine Levonorgestrel[J].Human Reproduction,2003,(03):77-84.
3Tonguc EA, Vat T, Yilmaz N, et al. Intrauterine device or estrogen treatment after hysteroscopic uterine septumresection. Int J Gynaecol Obstet ,2010,109 (3) :226 - 229.
4Fedele L, Bianehi S, Frontino G. Septums and synechiae:approa- ches to surgical correction. Clin Obstet Gynccol, 2006,49 ( 4 ) : 767 -788.
5Brucker SY, Rail K, Campo R, et al. Treatment of congenital mal- formations. Semin Reprod Med,2011,29(2) :101 -112.
6De Souza MA, Geber S. Doppler color flow analysis of the uterine ar- teries before and after intrauterine device insertion: a prospective stud- y. Ultrasound Med,2006,25(2) :153 - 157.
7Kurjak A, Kupesic S, Simunie V. Ultrasonic assessment of the peri - and postmenopausal ovary. Maturitas,2002,41 (4) :245 -254.
8Benshushana A,Pahielb O, Rojansky N, et al. IUD use and the risk of endometrial eanear. Eur J Obstet Cynecol Repred Biol, 2002, 105 (2) :166 - 169.
9Guleria K,Agarwal N, Mishra K, et al. Evaluation of endometrial ster- oid receptors and cell mitotic activity in women using copper intrau- terine device:Can Cu -T prevent endometrial cancer. Obstet Gynae- col Res,2004,30(3) :181 -187.
10Pakarinen P, Toivonen J, Luukkainen T. Randomized comparisonof levonorgestrel- and copper-releasing intrauterine systemsimmediately after abortion, with 5 years' follow-up. Contraception,2003,68(1):31-34.
